Furthermore, mutation characteristics of PSMD2 from the cBioPortal database also suggest that the altered group is associated with poor prognosis in overall survival, disease-specific survival, and progression-free survival in lung adenocarcinoma. The gene discussed is PSMD2; the disease is lung adenocarcinoma.